Interpace Biosciences®, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Discontinued Operations (Tables)

Discontinued Operations (Tables)

12 Months Ended

Dec. 31, 2014

Discontinued Operations and Disposal Groups [Abstract]

Schedule of Disposal Groups, Including Discontinued Operations, Income Statement, Balance Sheet and Additional Disclosures [Table Text Block]

The table below presents the significant components of Group DCA's, Pharmakon's and TVG’s results included in Loss from Discontinued Operations, Net of Tax in the consolidated statements of comprehensive loss for the years ended December 31, 2014 and 2013.



	For the Years Ended December 31,
	2014			2013
Revenue, net	$	3,214		$	4,309

Loss from discontinued operations, before income tax (1)	(6,666		)	(2,884		)
Income tax expense	5			5
Loss from discontinued operations, net of tax	$	(6,671	)	$	(2,889	)

The assets and liabilities classified as held-for-sale and discontinued operations relate to Group DCA, Pharmakon, and TVG. As of December 31, 2014 and December 31, 2013 these assets and liabilities are in the accompanying balance sheets as follows:



	For the Years Ended December 31,
	2014						2013
	Group DCA		Other		Total		Group DCA		Other		Total
Accounts receivable, net	$	613	$	—	$	613	$	519	$	—	$	519
Other	—		—		—		87		—		87
Other current assets	613		—		613		606		—		606
Property and equipment, net	—		—		—		1,221		—		1,221
Goodwill	1,295		—		1,295		2,523		—		2,523
Other	—		150		150		157		150		307
Other long-term assets	1,295		150		1,445		3,901		150		4,051
Total assets	$	1,908	$	150	$	2,058	$	4,507	$	150	$	4,657

Accounts payable	$	69	$	—	$	69	$	150	$	—	$	150
Unearned contract revenue	1,698		—		1,698		2,033		—		2,033
Accrued salary and bonus	550		—		550		266		—		266
Other	78		425		503		1,641		405		2,046
Other accrued expenses	2,395		425		2,820		4,090		405		4,495
Other long-term liabilities	—		329		329		198		619		817
Total liabilities	$	2,395	$	754	$	3,149	$	4,288	$	1,024	$	5,312

- Definition

Tabular disclosure of disposal groups, which may include the gain (loss) recognized in the income statement and the income statement caption that includes that gain (loss), amounts of revenues and pretax profit or loss reported in discontinued operations, the classification and carrying value of the assets and liabilities comprising the disposal group, and the segment in which the disposal group was reported. Also may include the amount of adjustments to amounts previously reported in discontinued operations such as resolution of contingencies arising from the disposal transaction or the operations of the component prior to disposal.

+ References + Details